AstraZeneca develops and commercializes innovative medicines focused on oncology, cardiovascular and metabolic diseases, respiratory conditions, and immunology. It also supplies vaccines developed in partnership with academic and other institutions to health authorities globally. Physicians and patients access its prescription products through healthcare systems in numerous countries.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 14,457 | — | 2,450 | — |
| Q3 2025 | 15,191 | — | 2,533 | — |
| Q4 2025 | 15,503 | — | 2,326 | — |
| Q1 2026 | 15,288 | — | 3,080 | — |
| Q2 2026 | 15,384 | 6.4% | 2,507 | 2.3% |
All markets — KeepWinning global stock screener
Other companies on London Stock Exchange: Shell plc (SHEL), BHP Group Limited (BHP), Banco Santander, S.A. (BNC), Rolls-Royce Holdings plc (RR), Rio Tinto Group (RIO), Unilever PLC (ULVR)